Close
4

Athena Athena

X

Company profile for ClostraBio

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
​ClostraBio has completed numerous supportive nonclinical studies to validate our CLB-004 program. The company has transferred our manufacturing process to a CDMO where we've successfully manufactured multiple kg-scale batches of material for nonclinical studies. With IND-enabling toxicology studies underway, we expect to initiate a clinical study in ~12 months. Given the expected favorable safety profile of our compounds,...
​ClostraBio has completed numerous supportive nonclinical studies to validate our CLB-004 program. The company has transferred our manufacturing process to a CDMO where we've successfully manufactured multiple kg-scale batches of material for nonclinical studies. With IND-enabling toxicology studies underway, we expect to initiate a clinical study in ~12 months. Given the expected favorable safety profile of our compounds, we intend to enroll patients with mild-moderate ulcerative colitis UC in a Phase 1a/b SAD-MAD clinical study to obtain safety/tolerability data, determine our Phase 2 dose, and generate exploratory efficacy endpoints.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
ClostraBio
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Chicago, IL
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY